Persistent Methicillin-resistant <i>Staphylococcus aureus</i> and Rate of FEV1 Decline in Cystic Fibrosis
Elliott C. Dasenbrook(Johns Hopkins University), Michael Boyle(McMaster University), Christian A. Merlo(Instituto Maimónides de Investigación Biomédica de Córdoba), Noah Lechtzin(Johns Hopkins University), Marie Diener‐West(Johns Hopkins University)
Cited by 321
Related Papers
Update on Key Emerging Challenges in Cystic Fibrosis
|Medical Principles and Practice|2014|3.7k
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>
|New England Journal of Medicine|2015|1.6k
Multiattribute and Single-Attribute Utility Functions for the Health Utilities Index Mark 3 System
|Medical Care|2002|1.3k
Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and Necrosis
|Science|1990|979
Inflammatory subtypes in asthma: Assessment and identification using induced sputum
|Respirology|2006|939